Reduction of secondary bile acids following microbiome pre-conditioning was associated with reduced breast cancer progression
Abstract
Breast cancer is the most common cause of cancer-related death in women worldwide. We previously reported that a primary bile acid mimetic reduced tumor progression in vivo. Here, we hypothesized that elevating primary bile acids through preconditioning of the gut microbiome may be an unexplored opportunity to improve breast cancer. We utilized the antibiotic vancomycin previously reported to deplete Gram-positive, anaerobic microbes that convert primary bile acids to secondary bile acids. Preconditioning with vancomycin significantly delayed tumor onset, decreased burden, promoted regression, and reduced the number of mice with lung colonization. Vancomycin reduced overall microbiome diversity and specific microbes in
Clostridium Cluster XIVa
, which associated with increased primary bile acid levels. We report that vancomycin significantly associated with elevated circulating bile acid tauro-alpha/beta-muricholic acid and reduced secondary bile acids that correlated with worsened tumor outcomes. Flow analysis of tumor content and systemic immune responses was associated with immune changes consistent with anti-tumor responses, including conventional dendritic cells and activated CD8 + T cells. In sum, we demonstrated that manipulation of the bile acid pools associated with improved breast cancer outcomes. The altered bile acids corresponded to an elevation of key immune cells, which may contribute to protection from primary breast cancer progression and lung colonization.
Read the paper
Related studies
- Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile: Role of Secondary Bile Acids
- Ketogenic diet alleviates colitis by reduction of colonic group 3 innate lymphoid cells through altering gut microbiome
- Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn's disease
- Diet, obesity, and the gut microbiome as determinants modulating metabolic outcomes in a non-human primate model
- Immune Impairment Associated with Vitamin A Deficiency: Insights from Clinical Studies and Animal Model Research
- Glyphosate-based herbicides influence antioxidants, reproductive hormones and gut microbiome but not reproduction: A long-term experiment in an avian model
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.